Neuroglia as a central element of neurological diseases: An underappreciated target for therapeutic intervention

Current Neuropharmacology

Volumn 12, Issue 4, 2014, Pages 303-307

  Peng, Liang ^a   Parpura, Vladimir ^b,c   Verkhratsky, Alexei ^d,e,f  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Rijeka   (Croatia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e BASQUE FOUNDATION FOR SCIENCE   (Spain)

^f LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

Author keywords

Astrocyte; Microglia; Neurodegeneration; Neuroglia; Neurological diseases; NG 2 cells; Oligodendrocyte; Psychiatric diseases; Therapy

Indexed keywords

CONNECTOME; EDITORIAL; GLIA; HUMAN; MACROPHAGE; MENTAL DISEASE; MYELINATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE;

EID: 84911466458     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X12999140829152550     Document Type: Editorial

References (71)

1. Kettenmann, H.; Ransom, B. R. Neuroglia. Oxford University Press: Oxford, 2013, pp. 864.
2. Verkhratsky, A.; Butt, A. M. Glial Physiology and Pathophysiology. Wiley-Blackwell: Chichester, 2013. DOI: 10. 1002/9781118402061.
3. Kimelberg, H. K. Functions of mature mammalian astrocytes: a current view. Neuroscientist, 2010, 16(1), 79-106. doi: 10. 1177/1073858409342593.
4. Kimelberg, H. K.; Nedergaard, M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics, 2010, 7(4), 338-353. DOI 10. 1016/j. nurt. 2010. 07. 006.
5. Allen, N. J.; Barres, B. A. Signaling between glia and neurons: focus on synaptic plasticity. Curr. Opin. Neurobiol., 2005, 15(5), 542-548. DOI: 10. 1016/j. conb. 2005. 08. 006.
6. Verkhratsky, A.; Nedergaard, M. Astroglial cradle in the life of the synapse. Philosophical Transactions of the Royal Society Series B, 2014, in press.
7. Boison, D.; Chen, J. F.; Fredholm, B. B. Adenosine signaling and function in glial cells. Cell Death Differ., 2010, 17(7), 1071-1082. doi: 10. 1038/cdd. 2009. 131.
8. Hertz, L.; Zielke, H. R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci., 2004, 27(12), 735-743. DOI: 10. 1016/j. tins. 2004. 10. 008.
9. Pellerin, L.; Magistretti, P. J. Sweet sixteen for ANLS. J. Cereb. Blood Flow Metab., 2012, 32(1), 1152-1166. doi: 10. 1038/jcbfm. 2011. 149.
10. Chen, Y.; Vartiainen, N. E.; Ying, W.; Chan, P. H.; Koistinaho, J.; Swanson, R. A. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J. Neurochem., 2001, 77(6), 1601-1610. DOI: 10. 1046/j. 1471-4159. 2001. 00374. x.
11. Sun, X.; Erb, H.; Murphy, T. H. Coordinate regulation of glutathione metabolism in astrocytes by Nrf2. Biochem. Biophys. Res. Commun., 2005, 326(2), 371-377. DOI: 10. 1016/j. bbrc. 2004. 11. 031.
12. Kriegstein, A.; Alvarez-Buylla, A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci., 2009, 32, 149-184. DOI: 10. 1146/annurev. neuro. 051508. 135600.
13. Abbott, N. J.; Patabendige, A. A.; Dolman, D. E.; Yusof, S. R.; Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol Dis., 2010, 37(1), 13-25. doi: 10. 3389/conf. fphar. 2010. 02. 00002.
14. Iadecola, C.; Nedergaard, M. Glial regulation of the cerebral microvasculature. Nat. Neurosci., 2007, 10(11), 1369-1376. doi: 10. 1038/nn2003.
15. Gourine, A. V.; Kasparov, S. Astrocytes as brain interoceptors. Exp. Physiol., 2011, 96(4), doi: 10. 1113/expphysiol. 2010. 053165.
16. Shimizu, H.; Watanabe, E.; Hiyama, T. Y.; Nagakura, A.; Fujikawa, A.; Okado, H.; Yanagawa, Y.; Obata, K.; Noda, M. Glial Nax channels control lactate signaling to neurons for brain [Na+] sensing. Neuron, 2007, 54(1), 59-72. DOI: 10. 1016/j. neuron. 2007. 03. 014.
17. Blutstein, T.; Haydon, P. G. The Importance of astrocyte-derived purines in the modulation of sleep. Glia, 2013, 61(2), 129-139. DOI: 10. 1002/glia. 22422.
18. Collingridge, G. L.; Peineau, S. Strippers reveal their depressing secrets: removing AMPA receptors. Neuron, 2014, 82(1), 3-6. DOI: 10. 1016/j. neuron. 2014. 03. 019.
19. Kettenmann, H.; Kirchhoff, F.; Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron, 2013, 77(1), 10-18. DOI: 10. 1016/j. neuron. 2012. 12. 023.
20. Tremblay, M. E.; Stevens, B.; Sierra, A.; Wake, H.; Bessis, A.; Nimmerjahn, A. The role of microglia in the healthy brain. J. Neurosci., 2011, 51(45), 16064-16069. doi: 10. 1523/JNEUROSCI. 4158-11. 2011.
21. Parpura, V.; Heneka, M. T.; Montana, V.; Oliet, S. H.; Schousboe, A.; Haydon, P. G.; Stout, R. F., Jr.; Spray, D. C.; Reichenbach, A.; Pannicke, T.; Pekny, M.; Pekna, M.; Zorec, R.; Verkhratsky, A. Glial cells in (patho)physiology. J. Neurochem., 2012, 121(1), 4-27. DOI: 10. 1111/j. 1471-4159. 2012. 07664. x.
22. Sofroniew, M. V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci., 2009, 32(12), 638-647. DOI: 10. 1016/j. tins. 2009. 08. 002.
23. Pekny, M.; Nilsson, M. Astrocyte activation and reactive gliosis. Glia, 2005, 50(4), 427-434. DOI: 10. 1002/glia. 20207.
24. Pekny, M.; Wilhelmsson, U.; Pekna, M. The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett., 2014, 565C, 30-38. DOI: 10. 1016/j. neulet. 2013. 12. 071.
25. Burda, J. E.; Sofroniew, M. V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron, 2014, 81(2), 229-248. DOI: 10. 1016/j. neuron. 2013. 12. 034.
26. Sofroniew, M. V.; Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol., 2010, 119(1), 7-35. doi: 10. 1007/s00401-009-0619-8.
27. Nishiyama, A.; Komitova, M.; Suzuki, R.; Zhu, X. Poly-dendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci., 2009, 10(1), 9-22. doi: 10. 1038/nrn2495.
28. Tripathi, R. B.; Rivers, L. E.; Young, K. M.; Jamen, F.; Richardson, W. D. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J. Neurosci., 2010, 30(48), 16383-16390. doi: 10. 1523/JNEUROSCI. 3411-10. 2010.
29. Zawadzka, M.; Rivers, L. E.; Fancy, S. P.; Zhao, C.; Tripathi, R.; Jamen, F.; Young, K.; Goncharevich, A.; Pohl, H.; Rizzi, M.; Rowitch, D. H.; Kessaris, N.; Suter, U.; Richardson, W. D.; Franklin, R. J. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell, 2010, 6(6), 578-590. DOI: 10. 1016/j. stem. 2010. 04. 002.
30. Hanisch, U. K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10(11), 1387-1394. doi: 10. 1038/nn1997.
31. Kettenmann, H.; Hanisch, U. K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev., 2011, 91(2), 461-553. DOI: 10. 1093/med/9780199794591. 003. 0019.
32. Ransohoff, R. M.; Perry, V. H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol., 2009, 27, 119-145. DOI: 10. 1146/annurev. immunol. 021908. 132528.
33. Benedetto, B.; Rupprecht, R. Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases. Curr. Neuropharmacol., 2013, 11, 171-185. DOI: 10. 2174/1570159X11311020004.
34. Coulter, D. A.; Eid, T. Astrocytic regulation of glutamate homeostasis in epilepsy. Glia, 2012, 60(8), 1215-1226.
35. De Keyser, J.; Mostert, J. P.; Koch, M. W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci., 2008, 267(1-2), 3-16. DOI: 10. 1016/j. jns. 2007. 08. 044.
36. Giaume, C.; Kirchhoff, F.; Matute, C.; Reichenbach, A.; Verkhratsky, A. Glia: the fulcrum of brain diseases. Cell Death Differ., 2007, 14(7), 1324-1335. doi: 10. 1038/sj. cdd. 4402144.
37. Goldman, S. A.; Nedergaard, M.; Windrem, M. S. Glial progenitor cell-based treatment and modeling of neurological disease. Science, 2012, 338(6106), 491-495. DOI: 10. 1126/science. 1218071.
38. Heneka, M. T.; Rodriguez, J. J.; Verkhratsky, A. Neuroglia in neurodegeneration. Brain Res. Rev., 2010, 63, 189-211.
39. Molofsky, A. V.; Krencik, R.; Ullian, E. M.; Tsai, H. H.; Deneen, B.; Richardson, W. D.; Barres, B. A.; Rowitch, D. H. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev., 2012, 26(9), 891-907. DOI: 10. 1101/gad. 188326. 112.
40. Rajkowska, G.; Stockmeier, C. A. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets, 2013, 14(11), 1225-36. DOI: 10. 2174/13894501113149990156.
41. Rodriguez, J. J.; Olabarria, M.; Chvatal, A.; Verkhratsky, A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ., 2009, 16(3), 378-385.
42. Rodriguez, J. J.; Verkhratsky, A. Neuroglial roots of neuro-degenerative diseases? Mol. Neurobiol., 2011, 43(2), 87-96. DOI 10. 1007/s12035-010-8157-x.
43. Seifert, G.; Steinhauser, C. Neuron-astrocyte signaling and epilepsy. Exp. Neurol., 2013, 244, 4-10. DOI: 10. 1016/j. expneurol. 2011. 08. 024.
44. Verkhratsky, A.; Rodriguez, J. J.; Parpura, V. Astroglia in neurological diseases. Future Neurol, 2013, 8(2), 149-158. DOI 10. 2217/M. 12. 90.
45. Verkhratsky, A.; Rodriguez, J. J.; Steardo, L. Astrogliopathology: A Central Element of Neuropsychiatric Diseases? Neuroscientist, 2013, Epub a head of print. doi: 10. 1177/1073858413510208.
46. Hassel, B.; Tessler, S.; Faull, R. L.; Emson, P. C. Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res., 2008, 33(2), 232-237. DOI 10. 1007/s11064-007-9463-1.
47. Hazell, A. S. Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy. Neurochem. Int., 2009, 55(1-3), 129-135. DOI: 10. 1016/j. neuint. 2009. 02. 020.
48. Hazell, A. S.; Sheedy, D.; Oanea, R.; Aghourian, M.; Sun, S.; Jung, J. Y.; Wang, D.; Wang, C. Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia, 2009, 58, 148-156. DOI: 10. 1002/glia. 20908.
49. 2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model. Neurobiol Dis., 2013, 58, 192-199. DOI: 10. 1016/j. nbd. 2013. 06. 002.
50. Rossi, D.; Brambilla, L.; Valori, C. F.; Roncoroni, C.; Crugnola, A.; Yokota, T.; Bredesen, D. E.; Volterra, A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ., 2008, 15(11), 1691-1700.
51. Sidoryk-Wegrzynowicz, M.; Aschner, M. Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacol. Toxicol., 2013, 14, 23. doi: 10. 1186/2050-6511-14-23.
52. Butterworth, R. F. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem. Int., 2010, 57(4), 383-388. DOI: 10. 1016/j. neuint. 2010. 03. 012.
53. Brusilow, S. W.; Koehler, R. C.; Traystman, R. J.; Cooper, A. J. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics, 2010, 7(4), 452-470. DOI 10. 1016/j. nurt. 2010. 05. 015.
54. Rangroo Thrane, V.; Thrane, A. S.; Wang, F.; Cotrina, M. L.; Smith, N. A.; Chen, M.; Xu, Q.; Kang, N.; Fujita, T.; Nagelhus, E. A.; Nedergaard, M. Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat. Med., 2013, 19(12), 1643-1648. doi: 10. 1038/nm. 3400.
55. Rose, C. F.; Verkhratsky, A.; Parpura, V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem. Soc. Trans., 2013, 41(6), 1518-1524. doi: 10. 1042/BST20130237.
56. Beauquis, J.; Pavia, P.; Pomilio, C.; Vinuesa, A.; Podlutskaya, N.; Galvan, V.; Saravia, F. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp. Neurol., 2013, 239, 28-37. DOI: 10. 1016/j. expneurol. 2012. 09. 009.
57. Olabarria, M.; Noristani, H. N.; Verkhratsky, A.; Rodriguez, J. J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia, 2010, 58, 831-838. DOI: 10. 1002/glia. 20967.
58. Verkhratsky, A.; Olabarria, M.; Noristani, H. N.; Yeh, C. Y.; Rodriguez, J. J. Astrocytes in Alzheimer's disease. Neurotherapeutics, 2010, 7(4), 399-412. DOI 10. 1016/j. nurt. 2010. 05. 017.
59. Kulijewicz-Nawrot, M.; Verkhratsky, A.; Chvatal, A.; Sykova, E.; Rodriguez, J. J. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J. Anat., 2012, 221(3), 252-262. DOI: 10. 1111/j. 1469-7580. 2012. 01536. x.
60. Yeh, C. Y.; Vadhwana, B.; Verkhratsky, A.; Rodriguez, J. J. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASNNeuro., 2011, 3(5), 271-279. DOI: 10. 1016/jjalz. 2010. 05. 728.
61. Rodriguez, J. J.; Noristani, H. N.; Hilditch, T.; Olabarria, M.; Yeh, C. Y.; Witton, J.; Verkhratsky, A. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease. Neurosci. Lett., 2013, 552, 129-134. DOI: 10. 1016/j. neulet. 2013. 06. 036.
62. Rodriguez, J. J.; Witton, J.; Olabarria, M.; Noristani, H. N.; Verkhratsky, A. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis., 2010, 1, e1. DOI: 10. 1016/j. neulet. 2013. 06. 036.
63. Tremblay, M. E.; Zettel, M. L.; Ison, J. R.; Allen, P. D.; Majewska, A. K. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia, 2012, 60(4), 541-558. DOI: 10. 1002/glia. 22287.
64. Rodriguez, J. J.; Noristani, H. N.; Verkhratsky, A. Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments. Brain Struct Funct., 2013, Epub a head of print. DOI 10. 1007/s00429-013-0693-5.
65. Krabbe, G.; Halle, A.; Matyash, V.; Rinnenthal, J. L.; Eom, G. D.; Bernhardt, U.; Miller, K. R.; Prokop, S.; Kettenmann, H.; Heppner, F. L. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One, 2013, 8(4), e60921. DOI: 10. 1371/journal. pone. 0060921.
66. Johansson, A.; Engler, H.; Blomquist, G.; Scott, B.; Wall, A.; Aquilonius, S. M.; Langstrom, B.; Askmark, H. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. J. Neurol. Sci., 2007, 255(1-2), 17-22. DOI: 10. 1016/jjns. 2007. 01. 057.
67. McGeer, P. L.; McGeer, E. G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve, 2002, 26(4), 459-470. DOI: 10. 1002/mus. 10191.
68. Kersaitis, C.; Halliday, G. M.; Kril, J. J. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol., 2004, 108(6), 515-523. DOI 10. 1007/s00401-004-0917-0.
69. Potts, R.; Leech, R. W. Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. Clin. Neuropathol., 2005, 24(6), 271-275. PMID: 16320822 [PubMed-indexed for MEDLINE].
70. Kielar, C.; Maddox, L.; Bible, E.; Pontikis, C. C.; Macauley, S. L.; Griffey, M. A.; Wong, M.; Sands, M. S.; Cooper, J. D. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis., 2007, 25(1), 150-162. DOI: 10. 1016/j. nbd. 2006. 09. 001.
71. Macauley, S. L.; Pekny, M.; Sands, M. S. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J. Neurosci., 2011, 31(43), 15575-15585. doi: 10. 1523/JNEUROSCI. 3579-11. 2011.